BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang S, Wang J, Liu F, Liu J, Cao G, Yang C, Liu W, Tu C, Zhu M, Xiong B. COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study. Hypertens Res. 2020;43:824-831. [PMID: 32483311 DOI: 10.1038/s41440-020-0485-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 51.0] [Reference Citation Analysis]
Number Citing Articles
1 Akbariqomi M, Hosseini MS, Rashidiani J, Sedighian H, Biganeh H, Heidari R, Moghaddam MM, Farnoosh G, Kooshki H. Clinical characteristics and outcome of hospitalized COVID-19 patients with diabetes: A single-center, retrospective study in Iran. Diabetes Res Clin Pract 2020;169:108467. [PMID: 32979419 DOI: 10.1016/j.diabres.2020.108467] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
2 Portacci A, Carpagnano GE, Tummolo MG, Santomasi C, Palma L, Fasano D, Resta E, Lozupone M, Solfrizzi V, Panza F, Resta O. COVID-19 Clinical Phenotypes and Short-term Outcomes: Differences Between the First and the Second Wave of Pandemic in Italy. Expert Rev Respir Med 2021. [PMID: 34311634 DOI: 10.1080/17476348.2021.1960824] [Reference Citation Analysis]
3 Sarı C, Şimşek EÇ, Özdoğan Ö. The outcomes of the postulated interaction between SARS-CoV-2 and the renin-angiotensin system on the clinician's attitudes toward hypertension treatment. J Hum Hypertens 2021;35:828-36. [PMID: 33168943 DOI: 10.1038/s41371-020-00436-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Wijeratne T, Gillard Crewther S, Sales C, Karimi L. COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception-A Systematic Review. Front Neurol 2020;11:607221. [PMID: 33584506 DOI: 10.3389/fneur.2020.607221] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
5 Alasia D, Owhonda G, Maduka O, Nwadiuto I, Arugu G, Tobin-West C, Azi E, Oris-Onyiri V, Urang IJ, Abikor V, Olofinuka AM, Adebiyi O, Somiari A, Avundaa H, Alali A. Clinical and epidemiological characteristics of 646 hospitalised SARS-Cov-2 positive patients in Rivers State Nigeria: a prospective observational study. Pan Afr Med J 2021;38:25. [PMID: 33777293 DOI: 10.11604/pamj.2021.38.25.26755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zeng Q, Li YZ, Dong SY, Chen ZT, Gao XY, Zhang H, Huang G, Xu Y. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension. Front Immunol 2020;11:596684. [PMID: 33362779 DOI: 10.3389/fimmu.2020.596684] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sarjerao Shirkande A, Abhijeet Shirkande A. Ayurvedic evaluation and treatment of Covid 19: A Case Report. J Ayurveda Integr Med 2021. [PMID: 34276164 DOI: 10.1016/j.jaim.2021.07.005] [Reference Citation Analysis]
8 UyaroĞlu OA, BaŞaran NÇ, ÖziŞik L, Dİzman GT, EroĞlu İ, Şahİn TK, TaŞ Z, İnkaya AÇ, TanriÖver MD, Metan G, GÜven GS, Ünal S. Thirty-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey: an observational, single-center study. Int J Qual Health Care 2021;33:mzaa144. [PMID: 33104780 DOI: 10.1093/intqhc/mzaa144] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
9 Khalili S, Moradi O, Kharazmi AB, Raoufi M, Sistanizad M, Shariat M. Comparison of Mortality Rate and Severity of Pulmonary Involvement in Coronavirus Disease-2019 Adult Patients With and Without Type 2 Diabetes: A Cohort Study. Can J Diabetes 2021;45:524-30. [PMID: 33339741 DOI: 10.1016/j.jcjd.2020.10.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Jakhmola S, Indari O, Chatterjee S, Jha HC. SARS-CoV-2, an Underestimated Pathogen of the Nervous System. SN Compr Clin Med 2020;:1-10. [PMID: 33015550 DOI: 10.1007/s42399-020-00522-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
11 Alamri F, Alsofayan Y, AlRuthia Y, Alahmari A, Almuzaini Y, Abo Gazalah F, Alradini F, Alaama T, Khan A. Predictors of Hospitalization Among Older Adults with COVID-19 in Saudi Arabia: A Cross-Sectional Study of a Nationally Representative Sample. Risk Manag Healthc Policy 2021;14:875-86. [PMID: 33692640 DOI: 10.2147/RMHP.S294786] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Engels Calvo V, Cruz Melguizo S, Abascal-Saiz A, Forcén Acebal L, Sánchez-Migallón A, Pintado Recarte P, Cuenca Marín C, Marcos Puig B, Del Barrio Fernández PG, Nieto Velasco O, de la Cruz Conty ML, Martínez-Perez O; Spanish Obstetric Emergency Group. Perinatal outcomes of pregnancies resulting from assisted reproduction technology in SARS-CoV-2-infected women: a prospective observational study. Fertil Steril 2021;116:731-40. [PMID: 33972083 DOI: 10.1016/j.fertnstert.2021.04.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ramphul K, Lohana P, Ramphul Y, Park Y, Mejias S, Dhillon BK, Sombans S, Verma R. Hypertension, diabetes mellitus, and cerebrovascular disease predispose to a more severe outcome of COVID-19. Arch Med Sci Atheroscler Dis 2021;6:e30-9. [PMID: 34027212 DOI: 10.5114/amsad.2021.105255] [Reference Citation Analysis]
14 Lee AC, Li WT, Apostol L, Ma J, Taub PR, Chang EY, Rajasekaran M, Ongkeko WM. Cardiovascular, cerebrovascular, and renal co-morbidities in COVID-19 patients: A systematic-review and meta-analysis. Comput Struct Biotechnol J 2021;19:3755-64. [PMID: 34221254 DOI: 10.1016/j.csbj.2021.06.038] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, Salazar-Mather TP, Dumenco L, Savaria MC, Aung SN, Flanigan T, Michelow IC. Predictors of COVID-19 severity: A literature review. Rev Med Virol 2021;31:1-10. [PMID: 32845042 DOI: 10.1002/rmv.2146] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 40.0] [Reference Citation Analysis]
16 Bezuidenhout MC, Wiese OJ, Moodley D, Maasdorp E, Davids MR, Koegelenberg CF, Lalla U, Khine-Wamono AA, Zemlin AE, Allwood BW. Correlating arterial blood gas, acid-base and blood pressure abnormalities with outcomes in COVID-19 intensive care patients. Ann Clin Biochem 2021;58:95-101. [PMID: 33103442 DOI: 10.1177/0004563220972539] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
17 Du Y, Zhou N, Zha W, Lv Y. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. Nutr Metab Cardiovasc Dis 2021;31:745-55. [PMID: 33549450 DOI: 10.1016/j.numecd.2020.12.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
18 Sonmez A, Demirci I, Haymana C, Tasci I, Dagdelen S, Salman S, Ata N, Sahin I, Emral R, Cakal E, Atmaca A, Sahin M, Celik O, Demir T, Ertugrul D, Unluturk U, Caglayan M, Satman I. Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia). J Diabetes 2021;13:585-95. [PMID: 33655669 DOI: 10.1111/1753-0407.13171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
19 Giri A, Srinivasan A, Sundar IK. COVID-19: Sleep, Circadian Rhythms and Immunity - Repurposing Drugs and Chronotherapeutics for SARS-CoV-2. Front Neurosci 2021;15:674204. [PMID: 34220430 DOI: 10.3389/fnins.2021.674204] [Reference Citation Analysis]
20 Bello B, Useh U. COVID-19: Are Non-Communicable Diseases Risk Factors for Its Severity? Am J Health Promot 2021;35:720-9. [PMID: 33576237 DOI: 10.1177/0890117121990518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 [DOI: 10.1101/2020.12.21.20248610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Potje SR, Costa TJ, Fraga-Silva TFC, Martins RB, Benatti MN, Almado CEL, de Sá KSG, Bonato VLD, Arruda E, Louzada-Junior P, Oliveira RDR, Zamboni DS, Becari C, Auxiliadora-Martins M, Tostes RC. Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients. Life Sci 2021;276:119376. [PMID: 33781826 DOI: 10.1016/j.lfs.2021.119376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
23 Hyoju SK, Baral B, Jha PK. Central catecholaminergic blockade with clonidine prevent SARS-CoV-2 complication: A case series. IDCases 2021;25:e01219. [PMID: 34249614 DOI: 10.1016/j.idcr.2021.e01219] [Reference Citation Analysis]
24 Yilmaz A, Sabirli R, Seyit M, Ozen M, Oskay A, Cakmak V, Goren T, Turkcuer I. Association between laboratory parameters and CT severity in patients infected with Covid-19: A retrospective, observational study. Am J Emerg Med 2021;42:110-4. [PMID: 33503532 DOI: 10.1016/j.ajem.2021.01.040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
25 Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, Gan H, Sun YL, Fu W, Li W, Liang HL, Cao YY, Yan Q, Cao C, Gao HY, Brüggen MC, van de Veen W, Sokolowska M, Akdis M, Akdis CA. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy 2021;76:428-55. [PMID: 33185910 DOI: 10.1111/all.14657] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 35.0] [Reference Citation Analysis]
26 Liang X, Shi L, Wang Y, Xiao W, Duan G, Yang H, Wang Y. The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates. J Infect 2020;81:e44-7. [PMID: 32593655 DOI: 10.1016/j.jinf.2020.06.060] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 19.0] [Reference Citation Analysis]
27 Scutelnic A, Heldner MR. Vascular Events, Vascular Disease and Vascular Risk Factors-Strongly Intertwined with COVID-19. Curr Treat Options Neurol 2020;22:40. [PMID: 33046957 DOI: 10.1007/s11940-020-00648-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
28 Ladopoulos T, Zand R, Shahjouei S, Chang JJ, Motte J, Charles James J, Katsanos AH, Kerro A, Farahmand G, Vaghefi Far A, Rahimian N, Ebrahimzadeh SA, Abedi V, Papathanasiou M, Labedi A, Schneider R, Lukas C, Tsiodras S, Tsivgoulis G, Krogias C. COVID-19: Neuroimaging Features of a Pandemic. J Neuroimaging 2021;31:228-43. [PMID: 33421032 DOI: 10.1111/jon.12819] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
29 D'Errico S, Zanon M, Montanaro M, Radaelli D, Sessa F, Di Mizio G, Montana A, Corrao S, Salerno M, Pomara C. More than Pneumonia: Distinctive Features of SARS-Cov-2 Infection. From Autopsy Findings to Clinical Implications: A Systematic Review. Microorganisms 2020;8:E1642. [PMID: 33114061 DOI: 10.3390/microorganisms8111642] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
30 Lorca LA, Torres-Castro R, Ribeiro IL, Benavente P, Pizarro M, San Cristobal B, Ugarte J, Laura C, Huanchicay C, Mamani A. Linguistic Validation and Cross-Cultural Adaptation of the Post-COVID-19 Functional Status Scale for the Chilean Population. Am J Phys Med Rehabil 2021;100:313-20. [PMID: 33496442 DOI: 10.1097/PHM.0000000000001706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
31 Zaccone G, Tomasoni D, Italia L, Lombardi CM, Metra M. Myocardial Involvement in COVID-19: an Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation. Curr Heart Fail Rep 2021;18:99-106. [PMID: 33890193 DOI: 10.1007/s11897-021-00509-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Preetam M, Anurag A. MuLBSTA score in COVID-19 pneumonia and prediction of 14-day mortality risk: A study in an Indian cohort. J Family Med Prim Care 2021;10:223-7. [PMID: 34017730 DOI: 10.4103/jfmpc.jfmpc_1766_20] [Reference Citation Analysis]
33 Luo L, Fu M, Li Y, Hu S, Luo J, Chen Z, Yu J, Li W, Dong R, Yang Y, Tu L, Xu X. The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis. Clin Cardiol 2020;43:1478-93. [PMID: 33026120 DOI: 10.1002/clc.23465] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 25.0] [Reference Citation Analysis]
34 Falzone L, Gattuso G, Tsatsakis A, Spandidos DA, Libra M. Current and innovative methods for the diagnosis of COVID‑19 infection (Review). Int J Mol Med 2021;47:100. [PMID: 33846767 DOI: 10.3892/ijmm.2021.4933] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
35 Cai CZ, Lin YL, Hu ZJ, Wong LP. Psychological and mental health impacts of COVID-19 pandemic on healthcare workers in China: A review. World J Psychiatry 2021;11:337-46. [PMID: 34327126 DOI: 10.5498/wjp.v11.i7.337] [Reference Citation Analysis]
36 Cheng L, Li H, Li L, Liu C, Yan S, Chen H, Li Y. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal 2020;34:e23618. [PMID: 33078400 DOI: 10.1002/jcla.23618] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 39.0] [Reference Citation Analysis]
37 Trump S, Lukassen S, Anker MS, Chua RL, Liebig J, Thürmann L, Corman VM, Binder M, Loske J, Klasa C, Krieger T, Hennig BP, Messingschlager M, Pott F, Kazmierski J, Twardziok S, Albrecht JP, Eils J, Hadzibegovic S, Lena A, Heidecker B, Bürgel T, Steinfeldt J, Goffinet C, Kurth F, Witzenrath M, Völker MT, Müller SD, Liebert UG, Ishaque N, Kaderali L, Sander LE, Drosten C, Laudi S, Eils R, Conrad C, Landmesser U, Lehmann I. Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19. Nat Biotechnol 2021;39:705-16. [PMID: 33361824 DOI: 10.1038/s41587-020-00796-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 33.0] [Reference Citation Analysis]
38 Mubarik S, Liu X, Eshak ES, Liu K, Liu Q, Wang F, Shi F, Wen H, Bai J, Yu C, Cao J. The Association of Hypertension With the Severity of and Mortality From the COVID-19 in the Early Stage of the Epidemic in Wuhan, China: A Multicenter Retrospective Cohort Study. Front Med (Lausanne) 2021;8:623608. [PMID: 34055822 DOI: 10.3389/fmed.2021.623608] [Reference Citation Analysis]
39 Ballow M, Haga CL. Why Do Some People Develop Serious COVID-19 Disease After Infection, While Others Only Exhibit Mild Symptoms? J Allergy Clin Immunol Pract 2021;9:1442-8. [PMID: 33486141 DOI: 10.1016/j.jaip.2021.01.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
40 De Sanctis V. Prevalence, Clinical Manifestations, and Biochemical Data of Hypertensive versus Normotensive Symptomatic Patients with COVID-19: A Comparative Study. Acta Biomed 2020;91:e2020164. [PMID: 33525211 DOI: 10.23750/abm.v91i4.10540] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
41 Booth A, Reed AB, Ponzo S, Yassaee A, Aral M, Plans D, Labrique A, Mohan D. Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis. PLoS One 2021;16:e0247461. [PMID: 33661992 DOI: 10.1371/journal.pone.0247461] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 35.0] [Reference Citation Analysis]
42 Saylik F, Akbulut T, Kaya S. Can C-Reactive Protein to Albumin Ratio Predict In-Hospital Death Rate Due to COVID-19 in Patients With Hypertension? Angiology 2021;:33197211012145. [PMID: 33902353 DOI: 10.1177/00033197211012145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]